Literature DB >> 25853334

Common histological patterns in glomerular epithelial cells in secondary focal segmental glomerulosclerosis.

Christoph Kuppe1, Hermann-Josef Gröne2, Tammo Ostendorf1, Toin H van Kuppevelt3, Peter Boor4, Jürgen Floege1, Bart Smeets1,5, Marcus J Moeller1.   

Abstract

Parietal epithelial cells (PECs) are involved in the development of sclerotic lesions in primary focal and segmental glomerulosclerosis (FSGS). Here, the role of PECs was explored in the more common secondary FSGS lesions in 68 patient biopsies, diagnosed with 11 different frequently or rarely encountered glomerular pathologies and additional secondary FSGS lesions. For each biopsy, one section was quadruple stained for PECs (ANXA3), podocytes (synaptopodin), PEC matrix (LKIV69), and Hoechst (nuclei), and a second was quadruple stained for activated PECs (CD44 and cytokeratin-19), PEC matrix, and nuclei. In all lesions, cellular adhesions (synechiae) between Bowman's capsule and the tuft were formed by cells expressing podocyte and/or PEC markers. Cells expressing PEC markers were detected in all FSGS lesions independent of the underlying glomerular disease and often stained positive for markers of activation. Small FSGS lesions, which were hardly identified on PAS sections previously, were detectable by immunofluorescent staining using PEC markers, potentially improving the diagnostic sensitivity to identify these lesions. Thus, similar patterns of cells expressing podocyte and/or PEC markers were found in the formation of secondary FSGS lesions independent of the underlying glomerular disease. Hence, our findings support the hypothesis that FSGS lesions follow a final cellular pathway to nephron loss that includes involvement of cells expressing PEC markers.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25853334     DOI: 10.1038/ki.2015.116

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  28 in total

Review 1.  Chronic kidney disease.

Authors:  Andrew S Levey; Josef Coresh
Journal:  Lancet       Date:  2011-08-15       Impact factor: 79.321

2.  Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis.

Authors:  Bart Smeets; Christoph Kuppe; Eva-Maria Sicking; Astrid Fuss; Peggy Jirak; Toin H van Kuppevelt; Karlhans Endlich; Jack F M Wetzels; Hermann-Josef Gröne; Jürgen Floege; Marcus J Moeller
Journal:  J Am Soc Nephrol       Date:  2011-06-30       Impact factor: 10.121

3.  Extensive podocyte loss triggers a rapid parietal epithelial cell response.

Authors:  Samy Hakroush; Angelika Cebulla; Thomas Schaldecker; Daniel Behr; Peter Mundel; Astrid Weins
Journal:  J Am Soc Nephrol       Date:  2013-12-12       Impact factor: 10.121

Review 4.  The role of podocytes in the development of glomerular sclerosis.

Authors:  W Kriz; M Elger; M Nagata; M Kretzler; S Uiker; I Koeppen-Hageman; S Tenschert; K V Lemley
Journal:  Kidney Int Suppl       Date:  1994-02       Impact factor: 10.545

5.  The parietal epithelial cell is crucially involved in human idiopathic focal segmental glomerulosclerosis.

Authors:  Henry Dijkman; Bart Smeets; Jeroen van der Laak; Eric Steenbergen; Jack Wetzels
Journal:  Kidney Int       Date:  2005-10       Impact factor: 10.612

6.  Pathologic classification of diabetic nephropathy.

Authors:  Thijs W Cohen Tervaert; Antien L Mooyaart; Kerstin Amann; Arthur H Cohen; H Terence Cook; Cinthia B Drachenberg; Franco Ferrario; Agnes B Fogo; Mark Haas; Emile de Heer; Kensuke Joh; Laure H Noël; Jai Radhakrishnan; Surya V Seshan; Ingeborg M Bajema; Jan A Bruijn
Journal:  J Am Soc Nephrol       Date:  2010-02-18       Impact factor: 10.121

7.  Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities.

Authors:  Bryan P Toole
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

8.  Recruitment of podocytes from glomerular parietal epithelial cells.

Authors:  Daniel Appel; David B Kershaw; Bart Smeets; Gang Yuan; Astrid Fuss; Björn Frye; Marlies Elger; Wilhelm Kriz; Jürgen Floege; Marcus J Moeller
Journal:  J Am Soc Nephrol       Date:  2008-12-17       Impact factor: 10.121

9.  Parietal epithelial cell activation marker in early recurrence of FSGS in the transplant.

Authors:  Huma Fatima; Marcus J Moeller; Bart Smeets; Hai-Chun Yang; Vivette D D'Agati; Charles E Alpers; Agnes B Fogo
Journal:  Clin J Am Soc Nephrol       Date:  2012-08-23       Impact factor: 8.237

10.  Detection of activated parietal epithelial cells on the glomerular tuft distinguishes early focal segmental glomerulosclerosis from minimal change disease.

Authors:  Bart Smeets; Fabien Stucker; Jack Wetzels; Isabelle Brocheriou; Pierre Ronco; Hermann-Josef Gröne; Vivette D'Agati; Agnes B Fogo; Toin H van Kuppevelt; Hans-Peter Fischer; Peter Boor; Jürgen Floege; Tammo Ostendorf; Marcus J Moeller
Journal:  Am J Pathol       Date:  2014-10-07       Impact factor: 4.307

View more
  33 in total

1.  Replenishment of the podocyte compartment by parietal epithelial cells.

Authors:  Jeffrey B Kopp
Journal:  Kidney Int       Date:  2015-11       Impact factor: 10.612

2.  Organoid single cell profiling identifies a transcriptional signature of glomerular disease.

Authors:  Jennifer L Harder; Rajasree Menon; Edgar A Otto; Jian Zhou; Sean Eddy; Noel L Wys; Christopher O'Connor; Jinghui Luo; Viji Nair; Cristina Cebrian; Jason R Spence; Markus Bitzer; Olga G Troyanskaya; Jeffrey B Hodgin; Roger C Wiggins; Benjamin S Freedman; Matthias Kretzler
Journal:  JCI Insight       Date:  2019-01-10

3.  Mechanisms of Scarring in Focal Segmental Glomerulosclerosis.

Authors:  Jianyong Zhong; Jacob B Whitman; Hai-Chun Yang; Agnes B Fogo
Journal:  J Histochem Cytochem       Date:  2019-05-22       Impact factor: 2.479

4.  Renin-Angiotensin-Aldosterone System Inhibition Increases Podocyte Derivation from Cells of Renin Lineage.

Authors:  Julia Lichtnekert; Natalya V Kaverina; Diana G Eng; Kenneth W Gross; J Nathan Kutz; Jeffrey W Pippin; Stuart J Shankland
Journal:  J Am Soc Nephrol       Date:  2016-04-14       Impact factor: 10.121

5.  Dual lineage tracing shows that glomerular parietal epithelial cells can transdifferentiate toward the adult podocyte fate.

Authors:  Natalya V Kaverina; Diana G Eng; Benjamin S Freedman; J Nathan Kutz; Tyler J Chozinski; Joshua C Vaughan; Jeffrey H Miner; Jeffrey W Pippin; Stuart J Shankland
Journal:  Kidney Int       Date:  2019-03-29       Impact factor: 10.612

6.  Proteomic Analysis Identifies Distinct Glomerular Extracellular Matrix in Collapsing Focal Segmental Glomerulosclerosis.

Authors:  Michael L Merchant; Michelle T Barati; Dawn J Caster; Jessica L Hata; Liliane Hobeika; Susan Coventry; Michael E Brier; Daniel W Wilkey; Ming Li; Ilse M Rood; Jeroen K Deegens; Jack F Wetzels; Christopher P Larsen; Jonathan P Troost; Jeffrey B Hodgin; Laura H Mariani; Matthias Kretzler; Jon B Klein; Kenneth R McLeish
Journal:  J Am Soc Nephrol       Date:  2020-06-19       Impact factor: 10.121

Review 7.  Steroid therapy in children with IgA nephropathy.

Authors:  Alexandra Cambier; Olivia Boyer; Georges Deschenes; James Gleeson; Anne Couderc; Julien Hogan; Thomas Robert
Journal:  Pediatr Nephrol       Date:  2019-02-18       Impact factor: 3.714

8.  Glomerular epithelial CD44 expression and segmental sclerosis in IgA nephropathy.

Authors:  Sewha Kim; Yon Hee Kim; Kyu Hun Choi; Hyeon Joo Jeong
Journal:  Clin Exp Nephrol       Date:  2015-12-28       Impact factor: 2.801

9.  Activated ERK1/2 increases CD44 in glomerular parietal epithelial cells leading to matrix expansion.

Authors:  Sebastian S Roeder; Taylor J Barnes; Jonathan S Lee; India Kato; Diana G Eng; Natalya V Kaverina; Maria W Sunseri; Christoph Daniel; Kerstin Amann; Jeffrey W Pippin; Stuart J Shankland
Journal:  Kidney Int       Date:  2016-12-18       Impact factor: 10.612

10.  Partial podocyte replenishment in experimental FSGS derives from nonpodocyte sources.

Authors:  Natalya V Kaverina; Diana G Eng; Remington R S Schneider; Jeffrey W Pippin; Stuart J Shankland
Journal:  Am J Physiol Renal Physiol       Date:  2016-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.